Moderna Inc (LTS:0A45)
$ 39.3575 -1.0175 (-2.51%) Market Cap: 15.50 Bil Enterprise Value: 9.98 Bil PE Ratio: 0 PB Ratio: 1.30 GF Score: 58/100

Moderna Inc at UBS BioPharma Conference Transcript

Nov 09, 2023 / 01:00PM GMT
Release Date Price: $70.42 (-1.32%)
Eliana Rachel Merle
UBS Investment Bank, Research Division - Analyst

Everyone, I'm Ellie Merle. Thank you so much for joining us at day 2 of the UBS Biopharma Conference here in sunny Miami. Very happy to have Moderna with us this morning. Joining us from Moderna is James Mock, Chief Financial Officer.

Questions & Answers

Eliana Rachel Merle
UBS Investment Bank, Research Division - Analyst

And with that, maybe just starting high level, walk us through the recent update with the 2023 guidance and how you think about COVID numbers from here?

James M. Mock
Moderna, Inc. - CFO

Okay. Well, first off, thanks for having us, Ellie. It's a pleasure to be here. And maybe let me just step back and talk about what we wanted to frame of it, why we get some 3 years of the financial framework here.

So we've always operated under the same principles. Those principles were that we could always have the ability to flex spending. We've showed that in the past. We're always concerned with financing risk. We've

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot